Completed NA INTERVENTIONAL NCT00716352

Prospective Registry of Outcomes and Management of Acute Ischaemic Syndromes

Sponsor: Bristol-Myers Squibb

Conditions Acute Coronary Syndromes Coronary Artery Disease

Interventions Educational intervention programme

Updated 6 times since 2017 Last updated: Jul 15, 2008 Started: Mar 31, 2004 Completion: Nov 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Acute Coronary Syndromes and Coronary Artery Disease and is currently completed. Bristol-Myers Squibb leads this study, which shows 6 recorded versions since 2004 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bristol-Myers Squibb
Royal Brompton & Harefield NHS Foundation Trust
Sanofi

Data source: Royal Brompton & Harefield NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aintree, United Kingdom , Airdrie, United Kingdom , Antrim, United Kingdom , Barnet, United Kingdom , Barnsley, United Kingdom , Basildon, United Kingdom , Basingstoke, United Kingdom , Belfast, United Kingdom , Birmingham, United Kingdom , Bridlington, United Kingdom and 26 more locations